Progressive, recurrent or primarily metastatic high-risk paediatric malignancies research hub

Combined antitumor therapy with ex vivo manipulated dendritic cells producing interleukin-12 in children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors

This study is testing a new treatment for children and young adults with certain high-risk cancers. It uses special immune cells grown in a lab to help their bodies fight the cancer. The main goal is to check how safe this new treatment is and if it has any serious side effects.